Chris Neamonitis

Stock Analyst at Piper Sandler

(n/a)
# 4,868
Out of 4,979 analysts
1
Total ratings
n/a
Success rate
-73.66%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Chris Neamonitis

InnovAge Holding
Mar 29, 2021
Initiates: Overweight
Price Target: $31
Current: $4.27
Upside: +626.00%